Comparison of DOTA and NODAGA as chelates for 68Ga-labelled CDP1 as novel infection PET imaging agents

被引:5
|
作者
Mdlophane, A. H. [1 ,2 ,3 ]
Ebenhan, T. [1 ,2 ,4 ]
Marjanovic-Painter, B. [3 ]
Govender, T. [5 ,6 ]
Sathekge, M. M. [1 ,2 ,4 ]
Zeevaart, J. R. [3 ,4 ,7 ]
机构
[1] Univ Pretoria, Nucl Med, Crn Malherbe & Steve Biko Rd, ZA-0001 Pretoria, South Africa
[2] Steve Biko Acad Hosp, Crn Malherbe & Steve Biko Rd, ZA-0001 Pretoria, South Africa
[3] South African Nucl Energy Corp Necsa, Radiochem, Pelindaba, Bldg P1600, ZA-0240 Brits, South Africa
[4] Pelindaba, Preclin Imaging Facil, Nucl Med Res Infrastruct NuMeRI, ZA-0240 Brits, South Africa
[5] Univ KwaZulu Natal, Sch Hlth Sci, Catalysis & Peptide Res Unit, ZA-4001 Durban, South Africa
[6] Univ KwaZulu Natal, Sch Chem & Phys, ZA-4001 Durban, South Africa
[7] North West Univ, Dept Sci & Technol Preclin Drug Dev Platform, 11 Hoffman St, ZA-2520 Potchefstroom, South Africa
关键词
CDP1; NODAGA; DOTA; Ga-68; Antimicrobial peptides; Infection imaging; PET; ANTIMICROBIAL PEPTIDES; UBIQUICIDIN; ANTIBACTERIAL; COMPLEXES; TRACER; GA-68; LL-37;
D O I
10.1007/s10967-019-06693-5
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The cathelicidin-derived peptide (CDP1) is a human antimicrobial peptide that preferentially targets bacterial membranes in response to infection. CDP1 was functionalised with NODAGA and DOTA for complexation with gallium-68 to evaluate its potential as an infection imaging tracer. The synthesis of [Ga-68]Ga-NODAGA-CDP1 and [Ga-68]Ga-DOTA-CDP1 were optimised for pH, molarity, incubation time and temperature, and product purification. The integrity and protein binding were investigated employing [Ga-68]GaCl3 and [Ga-68]Ga-DOTA-TATE as internal references. [Ga-68]Ga-NODAGA-CDP1 displayed good labelling properties with higher product yield compared to [Ga-68]Ga-DOTA-CDP1. In contrast, [Ga-68]Ga-DOTA-CDP1 showed better stability and is the preferred candidate for an in vivo investigation.
引用
收藏
页码:629 / 638
页数:10
相关论文
共 44 条
  • [31] 68Ga-DOTA-NT-20.3 Neurotensin Receptor 1 PET Imaging as a Surrogate for Neuroendocrine Differentiation of Prostate Cancer
    Wu, Wenyu
    Yu, Fei
    Zhang, Pengjun
    Bu, Ting
    Fu, Jingjing
    Ai, Shuyue
    You, Qinqin
    Shi, Liang
    Shao, Guoqiang
    Wang, Feng
    Hodolic, Marina
    Guo, Hongqian
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (09) : 1394 - 1400
  • [32] Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT Comparison With 18F-FDG PET/CT in 22 Different Cancer Types
    Cermik, Tevfik Fikret
    Ergul, Nurhan
    Yilmaz, Burcak
    Mercanoglu, Guldem
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (04) : E333 - E339
  • [33] Postoperative [68Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1
    Teske, Nico
    Biczok, Annamaria
    Quach, Stefanie
    Dekorsy, Franziska J.
    Forbrig, Robert
    Bodensohn, Raphael
    Niyazi, Maximilian
    Tonn, Joerg-Christian
    Albert, Nathalie L.
    Schichor, Christian
    Ueberschaer, Moritz
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 51 (01) : 206 - 217
  • [34] Postoperative [68Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1
    Nico Teske
    Annamaria Biczok
    Stefanie Quach
    Franziska J. Dekorsy
    Robert Forbrig
    Raphael Bodensohn
    Maximilian Niyazi
    Joerg-Christian Tonn
    Nathalie L. Albert
    Christian Schichor
    Moritz Ueberschaer
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 51 : 206 - 217
  • [35] PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates
    Beaino, Wissam
    Anderson, Carolyn J.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (11) : 1856 - 1863
  • [36] PET imaging of an optimized anti-PD-L1 probe 68Ga-NODAGA-BMS986192 in immunocompetent mice and non-human primates
    Zhou, Huimin
    Bao, Guangfa
    Wang, Ziqiang
    Zhang, Buchuan
    Li, Dan
    Chen, Lixing
    Deng, Xiaoyun
    Yu, Bo
    Zhao, Jun
    Zhu, Xiaohua
    EJNMMI RESEARCH, 2022, 12 (01)
  • [37] Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and 64Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors
    Oxboel, Jytte
    Brandt-Larsen, Malene
    Schjoeth-Eskesen, Christina
    Myschetzky, Rebecca
    El-Ali, Henrik H.
    Madsen, Jacob
    Kjaer, Andreas
    NUCLEAR MEDICINE AND BIOLOGY, 2014, 41 (03) : 259 - 267
  • [38] Preparation and Evaluation of [18F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [68Ga]Ga-DOTA/NOTA-NOC
    Dam, Johan Hygum
    Langkjaer, Niels
    Baun, Christina
    Olsen, Birgitte Brinkmann
    Nielsen, Aaraby Yoheswaran
    Thisgaard, Helge
    MOLECULES, 2022, 27 (20):
  • [39] Preclinical Evaluation of 68Ga-Labeled 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid-Ubiquicidin as a Radioligand for PET Infection Imaging
    Ebenhan, Thomas
    Zeevaart, Jan Rijn
    Venter, Jacobus D.
    Govender, Thavendran
    Kruger, Gert H.
    Jarvis, Neil V.
    Sathekge, Mike M.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (02) : 308 - 314
  • [40] PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide:: First results in patients with meningiomas
    Henze, M
    Schuhmacher, J
    Hipp, P
    Kowalski, J
    Becker, DW
    Doll, J
    Mäcke, HR
    Hofmann, M
    Debus, J
    Haberkorn, U
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (07) : 1053 - 1056